Nanopore Sequencing Market Size
| Study Period | 2019 - 2030 |
| Market Size (2025) | USD 379.17 Million |
| Market Size (2030) | USD 638.64 Million |
| CAGR (2025 - 2030) | 10.99% |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | High |
Major Players*Disclaimer: Major Players sorted in no particular order |
Nanopore Sequencing Market Analysis
The Nanopore Sequencing Market size is estimated at USD 379.17 million in 2025, and is expected to reach USD 638.64 million by 2030, at a CAGR of 10.99% during the forecast period (2025-2030).
The major factors driving the studied market are the growing advancements in gene sequencing technologies, rising investment in biotechnology research, increasing demand for personalized medicine, growing prevalence of genetic disorders, and growing strategic activities by key players in the market.
The substantial prevalence of genetic disorders such as sickle cell anemia and cystic fibrosis is expected to increase the demand for advanced sequencing technologies such as nanopore sequencing technologies for real-time DNA analysis and help rapidly diagnose rare genetic diseases. For instance, an article published in Frontiers in Haematology in August 2024, sickle cell disease (SCD) is prevalent in sub-Saharan Africa, India, and the Middle East, with approximately 300 thousand infants diagnosed annually. Similarly, an article published in Frontiers in Medicine in January 2024 mentioned that cystic fibrosis (CF) is among the most prevalent genetic disorders, affecting approximately 70 thousand individuals globally. Hence, the significant prevalence of genetic diseases is expected to increase the utilization of nanopore sequencing technologies for rapid diagnosis of genetic diseases and drive the studied market over the forecast period.
Furthermore, the increasing investment of in nanopore sequencing technologies increase the accessibility of this technology for rapid and efficient identification of the infectious disease outbreaks, which ultimately drive the studied market over the forecast period. For instance, in October 2023, Oxford Nanopore Technologies, the company delivering a new generation of nanopore-based molecular sensing technology, received EUR 70 million (USD 75.6 million) in investment from the BioMérieux, an in-vitro diagnostics company. The investment strengthens the relationship between the two companies, further aligning with Oxford Nanopore’s increasing focus on clinical markets through a partnership with BioMérieux. Hence, such strategic investments are expected to increase the accessibility of the nanopore technologies, which ultimately drive the studied market over the forecast period.
Thus, the increasing prevalence of genetic diseases such as sickle cell anemia, increasing investment in nanopore sequencing technologies are expected to drive the studied market over the forecast period. However, the complexity of data analysis and lack of standardization regarding the use of nanopore seqencing is expected to restrain the studied market over the forecast period.
Nanopore Sequencing Market Trends
DNA Sequencing Segment is Expected to Hold Significant Market Share Over the Forecast Period
DNA sequencing involves identifying the precise arrangement of nucleotides—adenine (A), thymine (T), cytosine (C), and guanine (G)—within a DNA molecule. This sequence contains the genetic information essential for living beings' growth, operation, and reproduction. The major factors driving the segment growth are the growing clinical advantages of nanopore technologies in DNA sequencing, increasing technological advancements, and growing strategic activities by key players in the market.
The increasing clinical applications of nanopore sequencing technologies for DNA sequencing are expected to increase the utilization of these technologies, which will accelerate studied segment revenue over the forecast period. For instance, according to an article published in Nature Chemistry in March 2024, DNA sequencing with nanopores has emerged as a powerful tool offering rapid readout, high accuracy, low cost, and portability. Nanopore sequencing is being applied in genome assembly, full-length DNA detection and base modification detection and in more specialized areas, such as rapid clinical diagnoses and outbreak surveillance. Hence, the increasing applications of the nanopore technologies in DNA sequencing is expected to increase the adoption of this technologies and boost the studied market over the forecast period.
Furthermore, the increasing strategic activities, such as product launches by key players are also expected to increase the demand for the nanopore technologies in DNA sequencing, which ultimately drive the studied market over the forecast period. For instance, in October 2023, Apple Inc., positioned Oxford Nanopore's DNA sequencing technology as a companion platform that can run on Apple devices equipped with its new M3 silicon chips, supporting broad access to biological insights in scientific research of health in Apple Inc.'s global product launch meeting. Hence, such strategic partnerships with tech companies is also expected to increase the adoption of the nanopore sequencing technologies, which ultimately drive the studied market over the forecast period.
Thus, increasing clinical applications of nanopore technologies in DNA sequencing and rising strategic activities such as partnerships the key players increases the utilization of nanopore sequencing devices, which ultimately boosting the studied segment growth over the forecast period.
North America is Expected to Hold the Significant Market Share Over the Forecast Period.
The nanopore sequencing market in North America is driven by factors such as advanced research infrastructure, rising prevalence of genetic diseases, growing interest in personalized medicine, technological advancements in gene sequencing tools, and rising strategic activities by key market players.
The rising technological advancements in gene-sequencing technology are expected to increase the accessibility of nanopore-sequencing technologies for various research purposes, which ultimately drive the studied market over the forecast period. For instance, in March 2024, Oxford Nanopore Technologies announced the early access launch of its all-in-one desktop sequencing device, the PromethION 2 Integrated (P2i), to complete its PromethION product range in the United States and Canada. This device is engineered with robust and powerful onboard computing capabilities. It facilitates real-time base-calling and post-run analysis directly within the device, eliminating the dependency on external computing resources. Hence, such technological advancements are expected to drive the studied market over the forecast period.
Furthermore, the increasing strategic activities, such as launch of novel products by key players, increase the accessibility of the nanopore sequencing technologies in the region, which ultimately drive the studied market over the forecast period. For instance, in August 2024, Asuragen, a company specializing in molecular diagnostics, launched a targeted nanopore sequencing assay in the United States that offers a streamlined approach to analyze several genes associated with common carrier screening conditions in genetics and oncology. Hence, such strategic activities increases the accessibility of nanopore sequencing technologies in the region, which ultimately drive the studied market over the forecast period.
Hence, the rising technological advancements in the gene sequencing field and growing strategic activities by the key players in the market are expected to increase the utilization of nanopore sequencing technologies in the rapid detection of genetic disorders and infectious dieses outbreak, which ultimately drive the studied market over the forecast period.
Nanopore Sequencing Industry Overview
The nanopore sequencing market is consolidated due to the presence of many global and regional players in the field. The major players in the market are adopting various strategic activities such as mergers and collaborations and raising funds for the development of new solutions. Some of the key players in the market are Illumina Inc, Qitan Tech., Cyclomics, Oxford Nanopore Technologies and Quantapore Inc., among other players.
Nanopore Sequencing Market Leaders
-
Qitan Tech.
-
Cyclomics
-
Oxford Nanopore Technologies
-
Illumina Inc.
-
Quantapore Inc.
- *Disclaimer: Major Players sorted in no particular order
Nanopore Sequencing Market News
- September 2024: MGI Tech Co., a startup based in China, revealed its global rights to commercialize and distribute the nanopore gene sequencing products CycloneSEQ-WT02 and CycloneSEQ-WY01. The CycloneSEQ technology shows promise in various genomics fields, incorporating several technological enhancements such as advanced protein engineering, an innovative flow cell design, and a state-of-the-art base calling algorithm, all aimed at achieving high accuracy and throughput in sequencing.
- August 2024: Novo Holding invested GBP 50 million (USD 63 million) in Oxford Nanopore Technologies. Oxford Nanopore’s analysis technology is currently used for DNA and RNA sequencing, allowing users to gain insights into a sample's epigenetics through real-time workflows. This investment reflected the company's confidence in Oxford Nanopore's platform and its growing potential within the biopharmaceutical sector.
Nanopore Sequencing Industry Segmentation
As per the scope of the report, nanopore sequencing devices use flow cells which contain an array of nanopores embedded in an electro-resistant membrane. Each nanopore corresponds to its own electrode connected to a channel and sensor chip, which measures the electric current that flows through the nanopore. When a molecule passes through a nanopore, the current is disrupted to produce a characteristic ‘squiggle’. The squiggle is then decoded using base calling algorithms to determine the DNA or RNA sequence in real time.
The nanopore sequencing market is segmented into product type, application, technology, end-user and geography. By product type, the market is segmented into instruments and consumables. By application, the market is segmented into clinical diagnostics, human genomics, plant and animal research and drug development and pharmacogenomics. By technology, the market is segmented into DNA sequencing, RNA sequencing, and epigenetic sequencing. By end user, the market is segmented into hospitals and diagnostic centers, academic and research institutes, pharmaceutical and biotechnology companies and other end-users. By geography, the market is segmented into North America, Europe, Asia-Pacific, and Rest of the World. For each segment, the market size is provided in terms of USD value.
| By Product Type | Instruments | ||
| Consumables | |||
| By Application | Clinical Diagnostics | ||
| Human Genomics | |||
| Plant and Animal Research | |||
| Drug Development and Pharmacogenomics | |||
| By Technology | DNA Sequencing | ||
| RNA Sequencing | |||
| Epigenetic Sequencing | |||
| By End User | Hospitals and Diagnostic Centers | ||
| Academic and Research Institutes | |||
| Pharmaceutical and Biotechnology Companies | |||
| Other End-Users | |||
| Geography | North America | United States | |
| Canada | |||
| Mexico | |||
| Europe | Germany | ||
| United Kingdom | |||
| France | |||
| Italy | |||
| Spain | |||
| Rest of Europe | |||
| Asia-Pacific | China | ||
| Japan | |||
| India | |||
| Australia | |||
| South Korea | |||
| Rest of Asia-Pacific | |||
| Rest of the World | |||
Nanopore Sequencing Market Research FAQs
How big is the Nanopore Sequencing Market?
The Nanopore Sequencing Market size is expected to reach USD 379.17 million in 2025 and grow at a CAGR of 10.99% to reach USD 638.64 million by 2030.
What is the current Nanopore Sequencing Market size?
In 2025, the Nanopore Sequencing Market size is expected to reach USD 379.17 million.
Who are the key players in Nanopore Sequencing Market?
Qitan Tech., Cyclomics, Oxford Nanopore Technologies, Illumina Inc. and Quantapore Inc. are the major companies operating in the Nanopore Sequencing Market.
Which is the fastest growing region in Nanopore Sequencing Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).
Which region has the biggest share in Nanopore Sequencing Market?
In 2025, the North America accounts for the largest market share in Nanopore Sequencing Market.
What years does this Nanopore Sequencing Market cover, and what was the market size in 2024?
In 2024, the Nanopore Sequencing Market size was estimated at USD 337.50 million. The report covers the Nanopore Sequencing Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Nanopore Sequencing Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
Nanopore Sequencing Industry Report
Statistics for the 2025 Nanopore Sequencing market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Nanopore Sequencing analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.
